The question is rarely whether you have patient engagement activity. The question is whether it is doing what you believe it is doing — and whether the right things are being measured. A structured assessment finds the gap between stated ambition and operational reality, and turns it into a prioritised action plan.
→ Audit your current patient engagement portfolio across brands, markets, and functions — mapping what exists, who owns it, and what it is actually designed to achieve
→ Assess programme integration: how closely each initiative is connected to the prescribing, dispensing, and onboarding workflow rather than running alongside it
→ Evaluate measurement frameworks against clinical and commercial outcome relevance — identifying where KPIs measure attention rather than follow-through
→ Interview internal stakeholders across Medical, Commercial, Digital, and Regulatory to identify where structural misalignment is undermining programme performance
→ Map early drop-off patterns against programme touchpoints to identify where patients are being lost and where intervention is absent
→ Assess the governance health of each programme: funding durability, brand transition risk, and whether institutional learning is accumulating or being lost
→ Identify the highest-leverage opportunity within your current model — the single change most likely to shift persistence outcomes within 12 months
→ Benchmark patient engagement maturity against cross-industry standards, including leading examples from immunology, neurology, and allergy
→ Deliver a structured findings report with prioritised recommendations, framed for leadership decision-making rather than operational review
→ Define the strategic brief for the next phase of programme development, with clear outcome targets and a governance model built in from the start